Class II · Moderate risk
Famotidine tablets
CGMP Deviations: Firm did not adequately investigate customer complaints.
FDA drug recalls in 2015
Every FDA drug recall initiated in 2015, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
1,733 recalls, newest first.
Class II · Moderate risk
Clarithromycin tablets
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class II · Moderate risk
Azithromycin tablets
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class II · Moderate risk
Azithromycin tablets
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class II · Moderate risk
Azithromycin tablets
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class II · Moderate risk
Amlodipine besylate tablets
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class II · Moderate risk
Amlodipine besylate tablets
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class II · Moderate risk
Amlodipine besylate tablets
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class II · Moderate risk
Enalapril maleate and hydrochlorothiazide tablets USP
Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.
Class II · Moderate risk
Losartan potassium tablets USP
Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.
Class II · Moderate risk
Losartan potassium tablets USP
Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.
Class II · Moderate risk
Losartan potassium tablets USP
Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.
Class II · Moderate risk
Gentamicin Sulfate
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Ganciclovir Sodium
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Fluorouracil 4250mg / D5W 285mL
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
HYDROmorphone HCl PF
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Ceftazidime 2 gm / NS 50mL
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Morphine Sulfate
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Cefepime HCl
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Potassium Chloride
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Vancomycin 1000mg / NS 100mL
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Vancomycin 750 mg/NS 100 ml accuflo
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
GENTAMICIN 14.4 mg / NS 30 mL SYRINGE
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Pfizerpen-G 4.2 MU / SW 240 mL AccuFlo
Lack of Assurance of Sterility: Sterility of product is not assure
Class II · Moderate risk
Cefepime HCl
Lack of Assurance of Sterility: Sterility of product is not assured